These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 29852782)

  • 41. Gastric neuroendocrine neoplasms and proton pump inhibitors: fact or coincidence?
    Cavalcoli F; Zilli A; Conte D; Ciafardini C; Massironi S
    Scand J Gastroenterol; 2015; 50(11):1397-403. PubMed ID: 26059834
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.
    Freedberg DE; Kim LS; Yang YX
    Gastroenterology; 2017 Mar; 152(4):706-715. PubMed ID: 28257716
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Does long-term profound inhibition of gastric acid secretion increase the risk of ECL cell-derived tumors in man?
    Waldum HL; Hauso Ø; Brenna E; Qvigstad G; Fossmark R
    Scand J Gastroenterol; 2016 Jul; 51(7):767-73. PubMed ID: 26872579
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term use of proton pump inhibitors does not affect ectopic and metachronous recurrence of gastric cancer after endoscopic treatment.
    Oura H; Matsumura T; Kawasaki Y; Okimoto K; Ishikawa K; Kaneko T; Tokunaga M; Oike T; Imai Y; Yokoyama Y; Akizue N; Maruoka D; Ohta Y; Saito K; Nakagawa T; Arai M; Kato J; Kato N
    Scand J Gastroenterol; 2020 Feb; 55(2):209-215. PubMed ID: 32008404
    [No Abstract]   [Full Text] [Related]  

  • 45. Overutilization of proton pump inhibitors: a review of cost-effectiveness and risk [corrected].
    Heidelbaugh JJ; Goldberg KL; Inadomi JM
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S27-32. PubMed ID: 19262544
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proton pump inhibitors (PPIs) and cancer. What should patients with gastroesophageal reflux disease candidates for PPIs therapy who refuse to comply with treatment know?
    Ruiz Pardo J; Sánchez Fuentes PA; Belda Lozano R; Vidaña Márquez E
    Rev Esp Enferm Dig; 2024 Jul; 116(7):395-396. PubMed ID: 37882179
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison table: Drugs for GERD and peptic ulcer disease.
    Med Lett Drugs Ther; 2018 Jan; 60(1538):e16-e18. PubMed ID: 29309400
    [No Abstract]   [Full Text] [Related]  

  • 48. Association between proton pump inhibitor use and gastric cancer: a population-based cohort study using two different types of nationwide databases in Korea.
    Seo SI; Park CH; You SC; Kim JY; Lee KJ; Kim J; Kim Y; Yoo JJ; Seo WW; Lee HS; Shin WG
    Gut; 2021 Nov; 70(11):2066-2075. PubMed ID: 33975868
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rebound Acid Hypersecretion after Withdrawal of Long-Term Proton Pump Inhibitor (PPI) Treatment-Are PPIs Addictive?
    Namikawa K; Björnsson ES
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791497
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drugs for GERD and peptic ulcer disease.
    Med Lett Drugs Ther; 2018 Jan; 60(1538):9-16. PubMed ID: 29309399
    [No Abstract]   [Full Text] [Related]  

  • 51. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Numans ME; Bonis PA; Lau J
    Cochrane Database Syst Rev; 2000; (2):CD002095. PubMed ID: 10796857
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
    Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
    J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
    Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
    Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Medical treatments of reflux esophagitis - Proton pump inhibitors and histamine H2 receptor antagonists -].
    Kinoshita Y; Ishimura N
    Nihon Rinsho; 2016 Aug; 74(8):1304-1310. PubMed ID: 30562433
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The use of proton pump inhibitors in children: a comprehensive review.
    Gibbons TE; Gold BD
    Paediatr Drugs; 2003; 5(1):25-40. PubMed ID: 12513104
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term proton pump inhibitor usage and the association with pancreatic cancer in Sweden.
    Brusselaers N; Sadr-Azodi O; Engstrand L
    J Gastroenterol; 2020 Apr; 55(4):453-461. PubMed ID: 31811561
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gastric neuroendocrine carcinoma after long-term use of proton pump inhibitor.
    Jianu CS; Lange OJ; Viset T; Qvigstad G; Martinsen TC; Fougner R; Kleveland PM; Fossmark R; Hauso Ø; Waldum HL
    Scand J Gastroenterol; 2012 Jan; 47(1):64-7. PubMed ID: 22087794
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Management of severe gastroesophageal reflux disease.
    DiPalma JA
    J Clin Gastroenterol; 2001 Jan; 32(1):19-26. PubMed ID: 11154163
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Does fasting serum gastrin predict gastric acid suppression in patients on proton-pump inhibitors?
    Bonapace ES; Fisher RS; Parkman HP
    Dig Dis Sci; 2000 Jan; 45(1):34-9. PubMed ID: 10695611
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proton pump inhibitors: the good, the bad, and the unwanted.
    Chubineh S; Birk J
    South Med J; 2012 Nov; 105(11):613-8. PubMed ID: 23128806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.